These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 35236774)

  • 21. A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney Organoids.
    Wysocki J; Ye M; Hassler L; Gupta AK; Wang Y; Nicoleascu V; Randall G; Wertheim JA; Batlle D
    J Am Soc Nephrol; 2021 Apr; 32(4):795-803. PubMed ID: 33526471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.
    Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F
    Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?
    Nicolau LAD; Magalhães PJC; Vale ML
    Med Hypotheses; 2020 Oct; 143():109886. PubMed ID: 32504925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation and Characterization of a SARS-CoV-2-Susceptible Mouse Model Using Adeno-Associated Virus (AAV6.2FF)-Mediated Respiratory Delivery of the Human ACE2 Gene.
    Tailor N; Warner BM; Griffin BD; Tierney K; Moffat E; Frost K; Vendramelli R; Leung A; Willman M; Thomas SP; Pei Y; Booth SA; Embury-Hyatt C; Wootton SK; Kobasa D
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19.
    Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A
    Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities.
    Pang XC; Zhang HX; Zhang Z; Rinkiko S; Cui YM; Zhu YZ
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33396184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.
    Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID-19 disease.
    Khoury EE; Knaney Y; Fokra A; Kinaneh S; Azzam Z; Heyman SN; Abassi Z
    J Cell Mol Med; 2021 Apr; 25(8):3840-3855. PubMed ID: 33660945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACE2, Much More Than Just a Receptor for SARS-COV-2.
    Samavati L; Uhal BD
    Front Cell Infect Microbiol; 2020; 10():317. PubMed ID: 32582574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-autonomous requirement for ACE2 across organs in lethal mouse SARS-CoV-2 infection.
    Tang AT; Buchholz DW; Szigety KM; Imbiakha B; Gao S; Frankfurter M; Wang M; Yang J; Hewins P; Mericko-Ishizuka P; Leu NA; Sterling S; Monreal IA; Sahler J; August A; Zhu X; Jurado KA; Xu M; Morrisey EE; Millar SE; Aguilar HC; Kahn ML
    PLoS Biol; 2023 Feb; 21(2):e3001989. PubMed ID: 36745682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
    Verdecchia P; Cavallini C; Spanevello A; Angeli F
    Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury.
    Yamaguchi T; Hoshizaki M; Minato T; Nirasawa S; Asaka MN; Niiyama M; Imai M; Uda A; Chan JF; Takahashi S; An J; Saku A; Nukiwa R; Utsumi D; Kiso M; Yasuhara A; Poon VK; Chan CC; Fujino Y; Motoyama S; Nagata S; Penninger JM; Kamada H; Yuen KY; Kamitani W; Maeda K; Kawaoka Y; Yasutomi Y; Imai Y; Kuba K
    Nat Commun; 2021 Nov; 12(1):6791. PubMed ID: 34815389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
    Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
    J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Manipulation of ACE2 expression in COVID-19.
    Chaudhry F; Lavandero S; Xie X; Sabharwal B; Zheng YY; Correa A; Narula J; Levy P
    Open Heart; 2020 Dec; 7(2):. PubMed ID: 33443121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice.
    Wang Y; Takeshita H; Yamamoto K; Huang Y; Wang C; Nakajima T; Nozato Y; Fujimoto T; Yokoyama S; Hongyo K; Nakagami F; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Rakugi H
    FASEB J; 2021 Mar; 35(3):e21419. PubMed ID: 33566370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.
    Monteil V; Kwon H; Prado P; Hagelkrüys A; Wimmer RA; Stahl M; Leopoldi A; Garreta E; Hurtado Del Pozo C; Prosper F; Romero JP; Wirnsberger G; Zhang H; Slutsky AS; Conder R; Montserrat N; Mirazimi A; Penninger JM
    Cell; 2020 May; 181(4):905-913.e7. PubMed ID: 32333836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Could SARS-CoV-2-induced lung injury be attenuated by vitamin D?
    Xiao D; Li X; Su X; Mu D; Qu Y
    Int J Infect Dis; 2021 Jan; 102():196-202. PubMed ID: 33129966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform.
    Mpekoulis G; Frakolaki E; Taka S; Ioannidis A; Vassiliou AG; Kalliampakou KI; Patas K; Karakasiliotis I; Aidinis V; Chatzipanagiotou S; Angelakis E; Vassilacopoulou D; Vassilaki N
    PLoS One; 2021; 16(6):e0253458. PubMed ID: 34185793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.